BUZZ - Deutsche Bank upgrades Royal Caribbean Cruises to "Buy", shares rise
路透社2026/09/28 13:21September 28 - ** Royal Caribbean Cruises (RCL.N) shares rose about 1% pre-market to $245.70
** Deutsche Bank upgraded the rating from “Hold” to “Buy”, stating that the 26% share price decline since August 5 has made the current risk-reward ratio more attractive
** The analysis report attributed the recent share price weakness to rising oil prices, as well as investor concerns over the sustainability of earnings growth amid Norwegian Cruise Line’s NCLH.N 2027 booking strategy and planned Caribbean capacity expansion
** It added that RCL is investing $3 billion in a joint venture, which will give it a 50% stake in Sandals Resorts; it noted investors initially appeared skeptical of the deal, but believes its economic benefits are quite attractive
** It pointed out that the positive share price reaction after Carnival Corp’s (CCL.N) financial report released on September 29 may also provide support to RCL
** Of 29 brokerage firms, 22 rate the stock as “Buy” or higher, while 7 recommend “Hold”; the median target price is $346.50
** As of yesterday’s close, the stock has fallen about 13% so far this year
(To assist non-English speakers, Reuters has automatically translated its reports into several other languages. Automated translation may contain errors or lack necessary context, and Reuters does not guarantee the accuracy of the translated texts. The automated translation is provided for reader convenience only. Reuters accepts no responsibility for any damage or loss caused by using the automated translation feature.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Masonglory prices US$ 1 million private placement at US$ 1.50 per share
1.1 Million XRP Ledger Payments: What Pushes It So High?
US President Trump to ease sanctions on Iran over nuclear progress
Market Chatter: BioNTech to Close 3 German Sites After Unsuccessful Sale Efforts